FOR IMMEDIATE RELEASE Orthomolecular Medicine News Service, March 20, 2026

🌟 Pearls & Purpose: 50 Years of Orthomolecular
      Medicine Leadership

Riordan Clinic 50th Anniversary Gala - April 25, 2026

The Riordan Clinic, one of the pioneering institutions in orthomolecular and integrative medicine, will mark its 50th anniversary with a commemorative gala, "Pearls & Purpose", on April 25, 2026, in Wichita, Kansas.

This milestone event represents not only a celebration of five decades of clinical innovation and research, but also a forward-looking commitment to expanding access, advancing science, and strengthening the future of systems-based medicine.

Event Details

• Date: Saturday, April 25, 2026
• Time: 6:00 - 10:00 PM
• Location: Mark Arts, Wichita, Kansas
• Attire: Cocktail

Further information and registration are available at: https://gala.riordanclinic.org/

The official invitation describes the evening as a celebration of "50 years of hope, healing, and health", honoring the community that has shaped the Riordan Clinic's mission while looking toward the next phase of integrative medicine.

Historical and Scientific Significance

Over the past half-century, the Riordan Clinic has contributed substantially to the development and advancement of:

• Orthomolecular medicine
• Nutritional and metabolic therapies
• High-dose intravenous vitamin C research
• Patient-centered integrative clinical care

These efforts have played a central role in challenging reductionist models of disease and in promoting a broader understanding of human health grounded in biochemical individuality and systems biology.

Current Need and Future Direction

Despite increasing demand for integrative care, access remains limited. Recent data indicate that 626 individuals sought care at the Riordan Clinic over a three-year period but were unable to proceed due to financial constraints.

The 50th Anniversary Gala is designed, in part, to address this gap and to support three core areas of the Riordan mission:

Patient Assistance

Expanding access to care for individuals facing financial barriers

Education

Training practitioners in integrative and orthomolecular approaches

Research

Advancing clinical and laboratory investigation, including ongoing work in intravenous vitamin C and related therapies

In addition, the initiative aims to support a long-term vision of enabling 10,000 new individuals ("co-learners") to begin care in the coming decade.

Sponsorship and Participation

A remaining sponsorship gap of approximately $25,000 has been identified to fully support the event and its associated mission activities.

Participation in the gala-whether through attendance, sponsorship, or outreach-provides an opportunity to contribute directly to the expansion of integrative medical care, education, and research.

OMNS Perspective

The Riordan Clinic's 50-year trajectory reflects a broader evolution in medicine-from a predominantly reductionist framework toward a more integrative, systems-oriented approach.

Orthomolecular medicine has long emphasized:

• Restoration of optimal biochemical environments
• Targeted nutritional and metabolic interventions
• Individualized, root-cause-focused care

As chronic disease prevalence continues to rise globally, these principles are increasingly relevant to both clinical practice and public health.

Conclusion

The "Pearls & Purpose" Gala represents a significant moment in the history of orthomolecular medicine. It offers an opportunity not only to recognize past achievements, but also to support the continued development of integrative, systems-based approaches to health and disease.

Further information, including registration and sponsorship details, is available at: https://gala.riordanclinic.org/

Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Jennifer L. Aliano, M.S., L.Ac., C.C.N. (USA)
Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Greg Beattie, Author (Australia)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Fabrice Leu, N.D., (Switzerland)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Diana MacKay (Gifford-Jones), M.P.P. (Canada)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Dr.Aarti Midha M.D., ABAARM (India)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiwei Ning, M.D., Ph.D. (China)
Zhiyong Peng, M.D. (China)
Pawel Pludowski, M.D. (Poland)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)
Dr. Sunil Wimalawansa, M.D., Ph.D. (Sri Lanka)

Andrew W. Saul, Ph.D. (USA), Founding & Former Editor
Richard Cheng, M.D., Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, Arabic Edition: Ayman Kamel, DVM, MBA (Egypt)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)

Comments and media contact: editor@orthomolecular.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.

To Subscribe at no charge: https://www.orthomolecular.org/subscribe.html

To Unsubscribe from this list: https://www.orthomolecular.org/unsubscribe.html